调节 ApoB mRNA 稳定性以调节脂肪肝疾病和动脉样硬化
Yiao Jiang1,2, Zhao Zhang1,2
1Center for the Genetics of Host Defense (Y.J., Z.Z.), University of Texas Southwestern Medical Center, Dallas.
Circulation
|December 25, 2025
概括
HELZ2 调节了阿波蛋白B (apoB) 的mRNA稳定性和脂质代谢. 调节HELZ2为心血管疾病和与代谢功能障碍相关的脂肪性肝病提供了潜在的治疗方法.
科学领域:
- 生物化学
- 遗传学
- 代谢疾病研究
背景情况:
- 脂蛋白B (apoB) 对于脂蛋白代谢至关重要,并与心血管和肝脏疾病有关.
- 与apoB蛋白降解不同的是,APOB mRNA稳定性的调节在很大程度上尚未被探索.
研究的目的:
- 研究HELZ2 (带指2的酶) 在调节APOB mRNA稳定性和脂质代谢中的作用.
- 探索HELZ2调节对代谢和心血管疾病的治疗潜力.
主要方法:
- 在小鼠中进行基因查以确定脂质代谢调节剂.
- 在不同饮食的小鼠中评估HELZ2突变和缺陷.
- 评估HELZ2与APOBmRNA的结合及其降解活性.
- 在Apoe-/和Ldlr-/小鼠模型中研究HELZ2对动脉样硬化的作用.
主要成果:
- 在HELZ2 (Colby) 中的功能增强突变通过增强HELZ2的APOB mRNA降解来增加肝脂积累.
- 在高脂肪饮食中,HELZ2 缺乏导致APOB mRNA增加和甘油三降低.
- 肝脏特异性的HELZ2诱导模仿了科尔比表型,降低了APOB mRNA并改变了脂质处理.
- 在小鼠模型中,科尔比突变可以预防动脉样硬化.
结论:
- HELZ2 是APOB mRNA稳定性和肝脂代谢的关键调节者.
- 向HELZ2活性为心血管疾病和与代谢功能障碍相关的脂肪性肝病提供了有前途的治疗途径.
相关概念视频
Cholesterol: Significance and Regulation
1.2K
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
1.2K
Lipid Catabolism
804
Triglycerides serve as crucial long-term energy storage molecules in microorganisms, providing a dense source of metabolic energy. Their breakdown is mediated by lipases, which hydrolyze triglycerides into glycerol and free fatty acids. Each of these components follows distinct metabolic pathways, ultimately contributing to ATP synthesis and cellular energy homeostasis.Glycerol MetabolismGlycerol, released from triglyceride hydrolysis, is phosphorylated by glycerol kinase to form...
804
Atherosclerosis III: Management
291
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
291
Regulation of the Unfolded Protein Response
2.9K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.9K
Regulation of Metabolism
11.3K
Cellular needs and conditions vary from cell to cell and change within individual cells over time. For example, the required enzymes and energetic demands of stomach cells are different from those of fat storage cells, skin cells, blood cells, and nerve cells. Furthermore, a digestive cell works much harder to process and break down nutrients during the time that closely follows a meal compared with many hours after a meal. As these cellular demands and conditions vary, so do the amounts and...
11.3K
Overview of Lipid Metabolism
4.7K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
4.7K


